Literature DB >> 34091143

Structural perspectives on HCV humoral immune evasion mechanisms.

Madhumati Sevvana1, Zhenyong Keck2, Steven Kh Foung3, Richard J Kuhn4.   

Abstract

The molecular mechanisms of hepatitis C virus (HCV) persistence and pathogenesis are poorly understood. The design of an effective HCV vaccine is challenging despite a robust humoral immune response against closely related strains of HCV. This is primarily because of the huge genetic diversity of HCV and the molecular evolution of various virus escape mechanisms. These mechanisms are steered by the presence of a high mutational rate in HCV, structural plasticity of the immunodominant regions on the virion surface of diverse HCV genotypes, and constant amino acid substitutions on key structural components of HCV envelope glycoproteins. Here, we review the molecular basis of neutralizing antibody (nAb)-mediated immune response against diverse HCV variants, HCV-steered humoral immune evasion strategies and explore the essential structural elements to consider for designing a universal HCV vaccine. Structural perspectives on key escape pathways mediated by a point mutation within the epitope, allosteric modulation of the epitope by distant mutations and glycan shift on envelope glycoproteins will be highlighted (abstract graphic).
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34091143      PMCID: PMC8319080          DOI: 10.1016/j.coviro.2021.05.002

Source DB:  PubMed          Journal:  Curr Opin Virol        ISSN: 1879-6257            Impact factor:   7.121


  55 in total

Review 1.  The challenge of developing a vaccine against hepatitis C virus.

Authors:  Xavier Forns; Jens Bukh; Robert H Purcell
Journal:  J Hepatol       Date:  2002-11       Impact factor: 25.083

Review 2.  Prospects for prophylactic and therapeutic vaccines against the hepatitis C viruses.

Authors:  Michael Houghton
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

3.  Hepatitis C virus E2 envelope glycoprotein core structure.

Authors:  Leopold Kong; Erick Giang; Travis Nieusma; Rameshwar U Kadam; Kristin E Cogburn; Yuanzi Hua; Xiaoping Dai; Robyn L Stanfield; Dennis R Burton; Andrew B Ward; Ian A Wilson; Mansun Law
Journal:  Science       Date:  2013-11-29       Impact factor: 47.728

4.  Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.

Authors:  Annalisa Meola; Alexander W Tarr; Patrick England; Luke W Meredith; C Patrick McClure; Steven K H Foung; Jane A McKeating; Jonathan K Ball; Felix A Rey; Thomas Krey
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

5.  An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein.

Authors:  Andrew I Flyak; Stormy E Ruiz; Jordan Salas; Semi Rho; Justin R Bailey; Pamela J Bjorkman
Journal:  Elife       Date:  2020-03-03       Impact factor: 8.140

6.  Vital Signs: Newly Reported Acute and Chronic Hepatitis C Cases - United States, 2009-2018.

Authors:  A Blythe Ryerson; Sarah Schillie; Laurie K Barker; Benjamin A Kupronis; Carolyn Wester
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-10       Impact factor: 17.586

7.  Racial and Ethnic Disparities in the Prevalence of Stress and Worry, Mental Health Conditions, and Increased Substance Use Among Adults During the COVID-19 Pandemic - United States, April and May 2020.

Authors:  Lela R McKnight-Eily; Catherine A Okoro; Tara W Strine; Jorge Verlenden; NaTasha D Hollis; Rashid Njai; Elizabeth W Mitchell; Amy Board; Richard Puddy; Craig Thomas
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-02-05       Impact factor: 17.586

Review 8.  Assembly of a functional HCV glycoprotein heterodimer.

Authors:  Muriel Lavie; Anne Goffard; Jean Dubuisson
Journal:  Curr Issues Mol Biol       Date:  2007-07       Impact factor: 2.081

9.  Genetic Diversity and Selective Pressure in Hepatitis C Virus Genotypes 1-6: Significance for Direct-Acting Antiviral Treatment and Drug Resistance.

Authors:  Lize Cuypers; Guangdi Li; Pieter Libin; Supinya Piampongsant; Anne-Mieke Vandamme; Kristof Theys
Journal:  Viruses       Date:  2015-09-16       Impact factor: 5.048

Review 10.  Glycan Shielding and Modulation of Hepatitis C Virus Neutralizing Antibodies.

Authors:  Muriel Lavie; Xavier Hanoulle; Jean Dubuisson
Journal:  Front Immunol       Date:  2018-04-27       Impact factor: 7.561

View more
  3 in total

Review 1.  Current view on novel vaccine technologies to combat human infectious diseases.

Authors:  Zrinka Matić; Maja Šantak
Journal:  Appl Microbiol Biotechnol       Date:  2021-12-10       Impact factor: 4.813

Review 2.  The Translational Bridge between Inflammation and Hepatocarcinogenesis.

Authors:  Sabine Gufler; Rita Seeboeck; Christoph Schatz; Johannes Haybaeck
Journal:  Cells       Date:  2022-02-03       Impact factor: 6.600

Review 3.  Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV.

Authors:  Naglaa H Shoukry
Journal:  Viruses       Date:  2021-09-18       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.